Your email has been successfully added to our mailing list.

×
0 0 0.0101676654770724 0 0 0 0 0
Stock impact report

BeiGene's tislelizumab successful in late-stage lung cancer study [Seeking Alpha]

BeiGene, Ltd. - American Depositary Shares (BGNE) 
Last beigene, ltd. - american depositary shares earnings: 3/2 04:05 pm Check Earnings Report
Company Research Source: Seeking Alpha
BeiGene (NASDAQ:BGNEpositive resultsPhase 3 clinical trialLLYThe study met the primary endpoint demonstrating a statistically significant improvement in progression-free survival (PFS) compared to pemetrexed and chemo alone.The company plans to file a supplemental marketing application in China for the indication and will present detailed results at future medical conferences. Show less Read more
Impact Snapshot
Event Time:
BGNE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for BGNE alerts
Opt-in for
BGNE alerts

from News Quantified
Opt-in for
BGNE alerts

from News Quantified